ALLEBY(SHANGHAI)MEDICAL TECHNOLOGY CO.,ITL – Trademark Portfolio

Entity Type: 99

ALLEBY(SHANGHAI)MEDICAL TECHNOLOGY CO.,ITL holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ALLEBY. The owner is based in SHANGHAI.

FLOOR 3, NO. 12-2, ZHONGSHAN 1ST ROAD,

CAOJING, TOWN, JINSHAN DISTRICT

SHANGHAI , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ALLEBY
ALLEBY
Registered 2021

Trademark Classifications

ALLEBY(SHANGHAI)MEDICAL TECHNOLOGY CO.,ITL's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does ALLEBY(SHANGHAI)MEDICAL TECHNOLOGY CO.,ITL have?

ALLEBY(SHANGHAI)MEDICAL TECHNOLOGY CO.,ITL has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does ALLEBY(SHANGHAI)MEDICAL TECHNOLOGY CO.,ITL file in?

ALLEBY(SHANGHAI)MEDICAL TECHNOLOGY CO.,ITL files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are ALLEBY(SHANGHAI)MEDICAL TECHNOLOGY CO.,ITL's most well-known trademarks?

ALLEBY(SHANGHAI)MEDICAL TECHNOLOGY CO.,ITL's registered trademark portfolio includes well-known marks such as ALLEBY. These are among 1 currently registered trademark in the portfolio.

What is ALLEBY(SHANGHAI)MEDICAL TECHNOLOGY CO.,ITL's trademark registration success rate?

ALLEBY(SHANGHAI)MEDICAL TECHNOLOGY CO.,ITL has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.